510(k) Report

510(k) · Cleared

Recalled · 2009

Accu-Chek Aviva Test Strips

K060620510(k) TraditionalCleared Aug 11, 2006156-day reviewClass II21 CFR 862.1345Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Aug 11, 2006 as substantially equivalent to K043474 (Roche Diagnostics Corp., 2005) after a 156-day review. Its family tree reaches back 2 generations to 2001. 1 of the 50 devices in its family, counting itself, has a Class I recall. 46 later devices descend from it. It has been recalled once.

Decided
Aug 11, 2006
Review
156 days
Class
Class II
Product code
NBW
Recalls
1
Predicates
1

Its longest line of descent runs back 2 generations to K010362 (2001). 3 ancestors in all. 46 later devices descend from it, 2 citing it directly. 1 of the 50 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2003: 1 other ancestor2011: 1 descendant cleared2007: 1 descendant cleared2012: 2 descendants cleared2014: 2 descendants cleared2013: 2 descendants cleared2015: 3 descendants cleared2016: 3 descendants cleared2023: 4 descendants cleared2018: 3 descendants cleared2022: 3 descendants cleared2020: 5 descendants cleared, 1 with a Class I recall12017: 2 descendants cleared2025: 5 descendants cleared2024: 3 descendants cleared2021: 2 descendants cleared2026: 5 descendants clearedK010362 · Accu-Chek Comfort Curve Test Strip · Roche Diagnostics Corp. · 2001 · recalledK043474 · Accu-Chek Aviva System · Roche Diagnostics Corp. · 2005 · recalled200020052010201520202025
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 4 descendants3 generations forward: 3 descendants4 generations forward: 3 descendants5 generations forward: 5 descendants6 generations forward: 7 descendants7 generations forward: 9 descendants, 1 with a Class I recall18 generations forward: 5 descendants9 generations forward: 5 descendants10 generations forward: 2 descendants11 generations forward: 1 descendant K043474 · Accu-Chek Aviva System · Roche Diagnostics Corp. · 2005 · recalledK010362 · Accu-Chek Comfort Curve Test Strip · Roche Diagnostics Corp. · 2001 · recalled0+5+10
  1. Root · 2 generations backK010362 Accu-Chek Comfort Curve Test StripRoche Diagnostics Corp. · 2001 · Recalled
  2. 1 generation backK043474 Accu-Chek Aviva SystemRoche Diagnostics Corp. · 2005 · Recalled
  3. This deviceK060620 Accu-Chek Aviva Test StripsRoche Diagnostics Corp. · 2006
  4. Descendant · cites it directly · 44 of its ownK101299 Accu-Chek Aviva Plus Blood Glucose Monitoring SystemRoche Diagnostics · 2011
  5. Descendant · 2 generations on · 37 of its ownK111353 Accu-Check Combo SystemRoche Diagnostics · 2012 · Recalled
  6. Descendant · 3 generations on · 33 of its ownK141929 Accu-Chek Connect Diabetes Management AppRoche Diagnostics Corporation · 2015 · Recalled
  7. Descendant · 4 generations on · 32 of its ownK150910 ACCU-CHEK Connect Diabetes Management AppRoche Diabetes Care, Inc. · 2015 · Recalled
  8. Descendant · 5 generations on · 21 of its ownK160629 InPenCompanion Medical, Inc. · 2016 · Recalled

Showing 5 of 46 descendants. See all descendants

Descendants cleared per year

2007: 12011: 12012: 22013: 22014: 22015: 32016: 32017: 22018: 32020: 52021: 22022: 32023: 42024: 32025: 52026: 5
2007high 5 (2020) · low 0 (2008)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 46 · See all
  • K101299Accu-Chek Aviva Plus Blood Glucose Monitoring SystemRoche Diagnostics · 2011 · cites it directly44descendants
  • K111353Accu-Check Combo SystemRoche Diagnostics · 2012 · 2 generations on37descendants
  • K141929Accu-Chek Connect Diabetes Management AppRoche Diagnostics Corporation · 2015 · 3 generations on33descendants
  • K150910ACCU-CHEK Connect Diabetes Management AppRoche Diabetes Care, Inc. · 2015 · 4 generations on32descendants
  • K160629InPenCompanion Medical, Inc. · 2016 · 5 generations on21descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K010362Accu-Chek Comfort Curve Test StripRoche Diagnostics Corp.20016
−1K043474Accu-Chek Aviva SystemRoche Diagnostics Corp.200510
0 (this device)K060620Accu-Chek Aviva Test StripsRoche Diagnostics Corp.2006—
+1K101299Accu-Chek Aviva Plus Blood Glucose Monitoring SystemRoche Diagnostics2011—
+2K111353Accu-Check Combo SystemRoche Diagnostics20123
+3K141929Accu-Chek Connect Diabetes Management AppRoche Diagnostics Corporation20151
+4K150910ACCU-CHEK Connect Diabetes Management AppRoche Diabetes Care, Inc.20156
+5K160629InPenCompanion Medical, Inc.20161

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
201110
201220
201320
201420
201530
201630
201720
201830
202051
202120
202230
202340
202430
202550
202650
FIG. 1 — Lineage of K060620, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K043474Accu-Chek Aviva System
Summary page 1
…system Classification name: 75, LFR, Glucose Dehydrogenase, glucose 3) Predicate The Roche Diagnostics ACCU-CHEK Aviva system cleared under K043474 device on April 27, 2005. 4) Device The ACCU-CHEK Aviva Test Strips are stored within a desiccated vial.…
Roche Diagnostics Corp.200510

Also cleared against K043474: 9 other devices →

What descends from it? (46)

See all 46

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K101299Accu-Chek Aviva Plus Blood Glucose Monitoring SystemRoche Diagnostics201144
K071493Clever Chek TD-4209 Blood Glucose Monitoring System, Model TD-4209, TD-4222, TD-4225Taidoc Technology Corporation20070

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 13, 2009Not classifiedZ-1593-2009OtherThe lancet cap may be missing, which could result in an unintended lancet stick to the user.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K193483Basal-IQ TechnologyTandem Diabetes Care, Inc. · 2020 · 7 generations on · ◆ in the 2020 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 5 years and passes through 1 company; a new generation was cleared every 4.1 years on median.
  • 2 of the 3 ancestors have a recall of any class.
  • Of its descendants, K101299 (Roche Diagnostics, 2011) has gone furthest, with 44 descendants of its own.
  • 9 other devices also cite its predicate K043474.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The ACCU-CHEK Aviva Test Strips are used with the ACCU-CHEK Aviva meter. The ACCU-CHEK Aviva test system is designed to quantitatively measure the concentration of glucose for monitoring glucose in the home or in health care facilities. Testing sites include traditional fingertip site along with palm, forearm, upper arm, thigh, and calf.

Professionals may use the test strips to test capillary, venous, arterial, and neonatal blood; home use is limited to capillary whole blood testing.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K060620: Accu-Chek Aviva Test Strips.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K060620

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026